会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Carbostyril derivatives
    • US4435404A
    • 1984-03-06
    • US261177
    • 1981-04-30
    • Takao NishiTatsuyoshi TanakaKazuyuki Nakagawa
    • Takao NishiTatsuyoshi TanakaKazuyuki Nakagawa
    • A61K31/47A61K31/4704A61P1/04A61P7/02A61P9/00A61P9/12A61P29/00A61P43/00C07D213/38C07D215/06C07D215/22C07D215/227C07D309/04C07D401/12C07D403/12C07D405/12C07D409/12
    • C07D215/227C07D213/38C07D215/22C07D309/04Y10S514/826Y10S514/926Y10S514/927
    • Novel carbostyril derivative and its salt represented by the general formula (1), ##STR1## wherein R.sup.1 is a hydrogen atom, a lower alkyl group, a lower alkenyl group or a phenyl-lower alkyl group; R.sup.2 is a hydrogen atom, a lower alkyl group or a group of the formula ##STR2## wherein A is a lower alkylene group; R.sup.3 is a lower alkyl group, a hydroxy lower alkyl group, a lower alkoxy-lower alkyl group, a lower alkanoyloxy-lower alkyl group or a benzoyloxy-lower alkyl group; and R.sup.4 is a C.sub.3-10 -cycloalkyl group which may have at least one hydroxyl group as the substituent(s) in the cycloalkyl ring, a C.sub.3-10 -cycloalkyl-lower alkyl group, a phenyl group, a phenyl-lower alkyl group which may have at least one lower alkoxy group as the substituent(s) in the phenyl ring, a lower alkyl group which may have at least one hydroxyl group as the substituent(s), a heterocyclic ring residue or a lower alkyl group having one heterocyclic ring residue as the substituent; further, R.sup.3, R.sup.4 and the adjacent nitrogen atom, as well as with or without another nitrogen atom, may form a group of the formula ##STR3## (wherein R.sup.5 is a phenyl group, a C.sub.3-10 -cycloalkyl group or a phenyl-lower alkyl group; and B is a methine group or a nitrogen atom); the carbon-carbon bond between the 3- and 4-positions in the carbostyril skeleton is a single or double bond; the substituted position of the group of the formula ##STR4## is any one of 5-, 6-, 7- or 8-position in the carbostyril skeleton; when the group of the formula ##STR5## is substituted at 5-, 6-, 7- or 8-position in the carbostyril skeleton, then R.sup.2 is a hydrogen atom or a lower alkyl group; alternatively, when R.sup.2 is a group of the formula ##STR6## then 5-, 6-, 7- and 8-positions in the carbostyril skeleton are hydrogen atoms and are not substituted with groups of the formula ##STR7## and when R.sup.3 is a lower alkyl group, then R.sup.4 should be neither of a C.sub.3-10 -cycloalkyl group, a C.sub.3-10 -cycloalkyl-lower alkyl group nor a lower alkyl group, having effects for preventing and treating thrombosis and embolism.
    • 6. 发明授权
    • Novel carbostyril derivatives
    • 新型喹诺酮衍生物
    • US4298739A
    • 1981-11-03
    • US142057
    • 1980-04-21
    • Takao NishiHiraki UedaKazuyuki Nakagawa
    • Takao NishiHiraki UedaKazuyuki Nakagawa
    • C07D215/22C07D215/227C07D215/26A61K31/47
    • C07D215/227C07D215/26
    • Novel carbostyril derivatives having platelet aggregation inhibitory action, antiinflamatory action, antiulcer action, vasodilatory action and phosphodiesterase inhibitory action and are useful for preventing or curing thrombus, arteriosclerosis, hypertension, asthma and other like diseases, and also useful as an antiinflamatory or anti-ulcer agent, represented by the formula ##STR1## wherein R.sup.1 is hydrogen, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, phenyl-C.sub.1-4 alkyl-; R.sup.2 is hydrogen, a halogen atom, hydroxy, phenyl-C.sub.1-4 alkoxy; R.sup.3 is hydrogen, hydroxy, C.sub.1-4 alkyl; R.sup.4 is C.sub.3-8 cycloalkyl, substituted or unsubstituted phenyl, C.sub.3-8 cycloalkyl-C.sub.1-4 alkyl, 2-(3,4-dimethoxyphenyl)-ethyl, R.sup.5 is hydrogen, C.sub.1-8 alkyl, C.sub.2-4 alkenyl, phenyl, C.sub.3-8 cycloalkyl, phenyl-C.sub.1-4 alkyl, C.sub.3-8 cycloalkyl-C.sub.1-4 alkyl, m is an integer of 1 - 3, l and n which may be same or different, and are respectively 0 or an integer of 1 - 7 and the sum of l and n is not exceeding 7, the carbon-carbon bond at 3- and 4-positions in the carbostyril skelton is either single or double bond.
    • 具有血小板聚集抑制作用,抗炎作用,抗溃疡作用,血管扩张作用和磷酸二酯酶抑制作用的新型喹诺酮衍生物,可用于预防或治疗血栓,动脉硬化,高血压,哮喘等疾病,并且还可用作抗炎或抗溃疡 其中R 1为氢,C 1-4烷基,C 2-4链烯基,苯基-C 1-4烷基 - ; R2是氢,卤素原子,羟基,苯基-C 1-4烷氧基; R3是氢,羟基,C1-4烷基; R4是C3-8环烷基,取代或未取代的苯基,C3-8环烷基-C1-4烷基,2-(3,4-二甲氧基苯基) - 乙基,R5是氢,C1-8烷基,C2-4烯基,苯基, C 3-8环烷基,苯基-C 1-4烷基,C 3-8环烷基-C 1-4烷基,m是1-3的整数,l和n可以相同或不同,分别为0或整数1 -7和n和n的总和不超过7,在喹诺酮骨架中3-和4-位的碳 - 碳键是单键或双键。
    • 7. 发明授权
    • Tetrazolylalkoxycarbostyril derivatives and pharmaceutical compositions
containing them
    • 四唑基烷氧基吡啶三唑衍生物和含有它们的药物组合物
    • US4277479A
    • 1981-07-07
    • US70710
    • 1979-08-29
    • Takao NishiKazuyuki Nakagawa
    • Takao NishiKazuyuki Nakagawa
    • C07D401/12A61K31/44A61K31/4427A61K31/47A61K31/4725A61P1/04A61P7/02A61P9/12A61P11/00A61P11/06A61P11/08A61P25/28A61P29/00A61P43/00C07D257/04C07D403/12C12N9/99
    • C07D257/04Y10S514/826
    • Novel tetrazolylalkoxycarbostyril derivative of the formula (I): ##STR1## wherein R.sup.1 is a hydrogen atom, a lower alkyl group, a low alkenyl group, a lower alkanoyl group, a benzoyl group or phenylalkyl group; R.sup.2 is a hydrogen atom, a lower alkyl group or a group of the formula ##STR2## R.sup.3 is a lower alkyl group, a cycloalkyl group, a cycloalkylalkyl group, a phenyl group or a phenylalkyl group; A is a lower alkylene group; the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is either single or double bond; and the substituted position of a group of the formula, ##STR3## in the carbostyril skeleton is either 4-, 5-, 6-, 7- or 8-position provided that the only one such group of the formula can be substituted in the whole carbostyril skeleton, thus when R.sup.2 in 4-position is a group of the formula ##STR4## then 5-, 6-, 7- or 8-position will have no such substituted group; furthermore, the phenyl group in the above-mentioned benzoyl group, phenylalkyl group or phenyl group may have substituted group(s).The above-mentioned novel tetrazolylalkoxycarbostyril derivatives have pharmacological activities such as platelet aggregation inhibitory action, antiinflammatory action, antiulcer action, vasodilatory action and phosphodiesterase inhibitory action and are useful as anti-thrombosis agent, cerebral blood flow improving agent, antiinflammatory agent, antiulcer agent, anti-hypertensive agent and anti-asthmatic agent.
    • 式(I)的新型四唑基烷氧基吡咯烷腈衍生物:其中R 1为氢原子,低级烷基,低级烯基,低级烷酰基,苯甲酰基或苯基烷基; R2是氢原子,低级烷基或下式的基团R3是低级烷基,环烷基,环烷基烷基,苯基或苯基烷基; A是低级亚烷基; 喹诺酮骨架中3-和4-位之间的碳 - 碳键是单键或双键; 并且喹诺酮骨架中的一组式()的取代位置是4-,5-,6-,7-或8-位,条件是式中唯一一个可以在 因此当4-位上的R2是式“IMAGE”的基团时,则5-,6-,7-或8-位将不具有这样的取代基; 此外,上述苯甲酰基中的苯基,苯基烷基或苯基可以具有取代基。 上述新型四唑基烷氧基吡咯烷腈衍生物具有药物活性,例如血小板聚集抑制作用,抗炎作用,抗溃疡作用,血管扩张作用和磷酸二酯酶抑制作用,可用作抗血栓形成剂,脑血流量改善剂,抗炎剂,抗溃疡剂, 抗高血压药和抗哮喘药。
    • 10. 发明授权
    • 3,4-Dihydrocarbostyril derivatives
    • 3,4-二氢喹诺酮衍生物
    • US4072683A
    • 1978-02-07
    • US630631
    • 1975-11-10
    • Kazuyuki NakagawaMinoru UchidaHiroaki Oka
    • Kazuyuki NakagawaMinoru UchidaHiroaki Oka
    • C07D215/26C07D215/22A61K31/47
    • C07D215/26
    • Novel (3'-alkylamino-2'-hydroxy)propoxy-3,4-dihydrocarbostyril derivatives having .beta.-adrenergic nerves blocking activity and hypotensive activity and useful as a remedy for angina pectoris, irregular pulse and hypertension, etc., represented by the formula, ##STR1## wherein R.sub.1 is hydrogen, C.sub.1 -C.sub.4 alkyl or aralkyl and R.sub.2 is C.sub.1 -C.sub.4 alkyl, are prepared by reacting a 3,4-dihydrocarbostyril derivative represented by the formula, ##STR2## wherein R.sub.1 is C.sub.1 -C.sub.4 alkyl or aralkyl, with an epihalogenohydrin represented by the formula, ##STR3## wherein X is halogen, reacting the resulting product with an alkylamine represented by the formula,R.sub.2 -- NH.sub.2wherein R.sub.2 is as defined above, and, if necessary, reducing the resulting product.
    • 具有β-肾上腺素能神经阻断活性和降血压活性的新型(3'-烷基氨基-2'-羟基)丙氧基-3,4-二氢喹诺酮衍生物,可用作心绞痛,不规则脉搏和高血压等的补救剂,由 其中R 1是氢,C 1 -C 4烷基或芳烷基,R 2是C 1 -C 4烷基的式,其中R 1是C 1 -C 4烷基,其由下式表示的3,4-二氢喹诺酮衍生物, 或芳烷基,与下式表示的表卤代醇,其中X是卤素,使得到的产物与由式R2-NH2表示的烷基胺反应,其中R2如上所定义,如果需要,还原所得的产物 。